MCC
VRTX icon

Money Concepts Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Money Concepts Capital’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-289
Closed -$83.5K – 2852
2022
Q4 		$83.5K Sell
289
-110
-28% -$33.5K ﹤0.01% 1046
2022
Q3 		$116K Buy
399
+212
+113% +$61K 0.01% 548
2022
Q2 		$54K Sell
187
-342
-65% -$91.5K ﹤0.01% 687
2022
Q1 		$138K Sell
529
-1,454
-73% -$345K 0.01% 881
2021
Q4 		$435K Buy
+1,983
New +$386K 0.04% 336
2021
Q1 		$311K Buy
+1,447
New +$318K 0.02% 409

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Money Concepts Capital's VRTX Position: Q1 2023 in Review

Money Concepts Capital sold out of Vertex Pharmaceuticals (VRTX) in Q1 2023, closing a stake of 289 shares — an estimated $83.5K sold.

Money Concepts Capital first reported a position in VRTX in Q1 2021 and held it in 6 quarters. The position peaked at $435K in Q4 2021. 1,207 funds tracked by Wall St. Rank hold VRTX as of Q1 2023.

  • Money Concepts Capital reported no remaining Vertex Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Money Concepts Capital sold 289 Vertex Pharmaceuticals shares in Q1 2023, an estimated $83.5K.
  • Money Concepts Capital first reported a position in Vertex Pharmaceuticals in Q1 2021 and held it in 6 quarters.
  • Money Concepts Capital's Vertex Pharmaceuticals position peaked at $435K in Q4 2021.
  • 1,207 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.